CIK 0001708599 · Non-accelerated filer<br>Smaller reporting company
Serina Therapeutics, Inc.
Sign in to watch- Ticker
- SER
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- AL
- Entity type
- operating
- EIN
- 821436829
- Phone
- (256) 327-9630
- Business address
- 601 GENOME WAY, SUITE 2001, HUNTSVILLE, AL, 35806
- Former names
- AgeX Therapeutics, Inc.
- 4 Planned sale Chief Scientific Officer sold 6,500 shares at $4.10 ($26,650)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Planned sale Chief Scientific Officer sold 3,398 shares at $4.24 ($14,408)
- 4 Planned sale Chief Scientific Officer sold 3,102 shares at $4.40 ($13,634)
- 4 Planned sale Chief Scientific Officer sold 5,551 shares at $4.96 ($27,541)
- 4 Planned sale Chief Scientific Officer sold 949 shares at $5.19 ($4,921)
- 4 Planned sale Chief Scientific Officer sold 6,500 shares at $4.97 ($32,287)
- 4 Planned sale Chief Scientific Officer sold 4,326 shares at $5.20 ($22,495)
- 4 Planned sale Chief Scientific Officer sold 47,674 shares at an average $6.95 ($331,418)
- 4 Planned sale Chief Scientific Officer sold 4,304 shares at an average $5.18 ($22,284)
- 4 Planned sale Chief Scientific Officer sold 5,500 shares at $5.25 ($28,875)
- 4 Planned sale Chief Scientific Officer sold 5,500 shares at $5.17 ($28,435)
- 4 Planned sale Chief Scientific Officer sold 4,196 shares at $6.50 ($27,274)
- 4 Open-market sale Chief Scientific Officer sold 6,500 shares at $5.89 ($38,285)
- 4 Open-market sale Chief Scientific Officer sold 6,500 shares at $5.34 ($34,710)
- 4 Open-market sale Chief Scientific Officer sold 6,500 shares at $5.01 ($32,565)
Page 3 of 9 · 177 filings